These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 38329909)
21. Oral fast-dissolving films containing lutein nanocrystals for improved bioavailability: formulation development, in vitro and in vivo evaluation. Liu C; Chang D; Zhang X; Sui H; Kong Y; Zhu R; Wang W AAPS PharmSciTech; 2017 Nov; 18(8):2957-2964. PubMed ID: 28462465 [TBL] [Abstract][Full Text] [Related]
22. Fabrication of solid lipid nanoparticles of lurasidone HCl for oral delivery: optimization, Patel MH; Mundada VP; Sawant KK Drug Dev Ind Pharm; 2019 Aug; 45(8):1242-1257. PubMed ID: 30880488 [No Abstract] [Full Text] [Related]
23. Lipid-coated nanocrystals of paclitaxel as dry powder for inhalation: Characterization, in-vitro performance, and pharmacokinetic assessment. Kumar M; Jha A; Bharti K; Manjit M; Kumbhar P; Dhapte-Pawar V; Mishra B Colloids Surf B Biointerfaces; 2024 May; 237():113865. PubMed ID: 38520950 [TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetic control of orally dosed cyclosporine A with mucosal drug delivery system. Yamada K; Ristroph KD; Kaneko Y; Lu HD; Prud'homme RK; Sato H; Onoue S Biopharm Drug Dispos; 2024 Jun; 45(3):117-126. PubMed ID: 38646776 [TBL] [Abstract][Full Text] [Related]
25. Investigating the role of Pluronic-g-Cationic polyelectrolyte as functional stabilizer for nanocrystals: Impact on Paclitaxel oral bioavailability and tumor growth. Sharma S; Verma A; Pandey G; Mittapelly N; Mishra PR Acta Biomater; 2015 Oct; 26():169-83. PubMed ID: 26265061 [TBL] [Abstract][Full Text] [Related]
26. Oral Delivery of Puerarin Nanocrystals To Improve Brain Accumulation and Anti-Parkinsonian Efficacy. Xiong S; Liu W; Li D; Chen X; Liu F; Yuan D; Pan H; Wang Q; Fang S; Chen T Mol Pharm; 2019 Apr; 16(4):1444-1455. PubMed ID: 30811206 [TBL] [Abstract][Full Text] [Related]
27. Characterization and evaluation of nanostructured lipid carrier as a vehicle for oral delivery of etoposide. Zhang T; Chen J; Zhang Y; Shen Q; Pan W Eur J Pharm Sci; 2011 Jun; 43(3):174-9. PubMed ID: 21530654 [TBL] [Abstract][Full Text] [Related]
28. Eplerenone nanocrystals engineered by controlled crystallization for enhanced oral bioavailability. Khan MA; Ansari MM; Arif ST; Raza A; Choi HI; Lim CW; Noh HY; Noh JS; Akram S; Nawaz HA; Ammad M; Alamro AA; Alghamdi AA; Kim JK; Zeb A Drug Deliv; 2021 Dec; 28(1):2510-2524. PubMed ID: 34842018 [TBL] [Abstract][Full Text] [Related]
29. Formulation, optimization, and in vitro-in vivo evaluation of olmesartan medoxomil nanocrystals. Jain S; Patel K; Arora S; Reddy VA; Dora CP Drug Deliv Transl Res; 2017 Apr; 7(2):292-303. PubMed ID: 28116656 [TBL] [Abstract][Full Text] [Related]
30. Pharmaceutical and pharmacokinetic characteristics of different types of fenofibrate nanocrystals prepared by different bottom-up approaches. Zhang H; Meng Y; Wang X; Dai W; Wang X; Zhang Q Drug Deliv; 2014 Dec; 21(8):588-94. PubMed ID: 24320001 [TBL] [Abstract][Full Text] [Related]
31. Nimodipine nanocrystals for oral bioavailability improvement: preparation, characterization and pharmacokinetic studies. Fu Q; Sun J; Zhang D; Li M; Wang Y; Ling G; Liu X; Sun Y; Sui X; Luo C; Sun L; Han X; Lian H; Zhu M; Wang S; He Z Colloids Surf B Biointerfaces; 2013 Sep; 109():161-6. PubMed ID: 23668980 [TBL] [Abstract][Full Text] [Related]
32. Preparation and in-vitro/in-vivo characterization of trans-resveratrol nanocrystals for oral administration. Singh SK; Makadia V; Sharma S; Rashid M; Shahi S; Mishra PR; Wahajuddin M; Gayen JR Drug Deliv Transl Res; 2017 Jun; 7(3):395-407. PubMed ID: 28194730 [TBL] [Abstract][Full Text] [Related]
33. Nanocrystal-loaded liposome for targeted delivery of poorly water-soluble antitumor drugs with high drug loading and stability towards efficient cancer therapy. Liang H; Zou F; Liu Q; Wang B; Fu L; Liang X; Liu J; Liu Q Int J Pharm; 2021 Apr; 599():120418. PubMed ID: 33647414 [TBL] [Abstract][Full Text] [Related]
34. The elucidation of key factors for oral absorption enhancement of nanocrystal formulations: In vitro-in vivo correlation of nanocrystals. Imono M; Uchiyama H; Yoshida S; Miyazaki S; Tamura N; Tsutsumimoto H; Kadota K; Tozuka Y Eur J Pharm Biopharm; 2020 Jan; 146():84-92. PubMed ID: 31816392 [TBL] [Abstract][Full Text] [Related]
35. Baicalin-berberine complex nanocrystals orally promote the co-absorption of two components. Li Z; Liu Y; Wang J; Feng X; Nwafor EO; Zhang Y; Liu R; Dang W; Zhang Q; Yu C; Pi J; Liu Z Drug Deliv Transl Res; 2022 Dec; 12(12):3017-3028. PubMed ID: 35476182 [TBL] [Abstract][Full Text] [Related]
36. Pickering Emulsions Enhance Oral Bioavailability of Curcumin Nanocrystals: The Effect of Oil Types. Sheng Y; Yu Q; Huang Y; Zhu Q; Chen Z; Wu W; Yi T; Lu Y Pharmaceutics; 2023 Apr; 15(5):. PubMed ID: 37242583 [TBL] [Abstract][Full Text] [Related]
37. Size effect of curcumin nanocrystals on dissolution, airway mucosa penetration, lung tissue distribution and absorption by pulmonary delivery. He Y; Liang Y; Mak JCW; Liao Y; Li T; Yan R; Li HF; Zheng Y Colloids Surf B Biointerfaces; 2020 Feb; 186():110703. PubMed ID: 31835185 [TBL] [Abstract][Full Text] [Related]
38. Spironolactone nanocrystals for oral administration: Different pharmacokinetic performances induced by stabilizers. Mu S; Li M; Guo M; Yang W; Wang Y; Li J; Fu Q; He Z Colloids Surf B Biointerfaces; 2016 Nov; 147():73-80. PubMed ID: 27490456 [TBL] [Abstract][Full Text] [Related]
39. Effect of Size on the Biodistribution and Blood Clearance of Etoposide-Loaded PLGA Nanoparticles. Yadav KS; Chuttani K; Mishra AK; Sawant KK PDA J Pharm Sci Technol; 2011; 65(2):131-9. PubMed ID: 21502074 [TBL] [Abstract][Full Text] [Related]
40. Enhanced oral bioavailability of glycyrrhetinic acid via nanocrystal formulation. Lei Y; Kong Y; Sui H; Feng J; Zhu R; Wang W Drug Deliv Transl Res; 2016 Oct; 6(5):519-25. PubMed ID: 27206446 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]